Who Handles Research Misconduct in 4 Countries?

Who handles research misconduct depends entirely on the jurisdiction: no single global regulator exists. The United States channels federally funded cases through the Office of Research Integrity (ORI) under 42 CFR Part 93; the UK relies on individual universities advised by the UK Research Integrity Office (UKRIO); Australia splits oversight between the NHMRC/ARC-run Australian Research Integrity Committee (ARIC) and institutions applying the Australian Code for the Responsible Conduct of Research; and Canada’s Tri-Agency Secretariat on Responsible Conduct of Research (SRCR) enforces the Tri-Agency Framework across CIHR, NSERC and SSHRC-funded work. In all four systems, the employing institution — not the national body — conducts the actual investigation.

Research misconduct is fabrication, falsification, or plagiarism in proposing, performing, reviewing, or reporting research — a definition first codified in US federal regulation and echoed, with local variation, across the other three systems discussed below.

Contents

• Who actually investigates research misconduct?
• United States: the Office of Research Integrity (ORI)
• United Kingdom: institutions advised by UKRIO
• Australia: NHMRC, ARC and the Australian Research Integrity Committee
• Canada: the Tri-Agency Framework and SRCR
• Side-by-side comparison of powers and remit
• Answer-first Q&A
• What this means for institutions and researchers

Who actually investigates research misconduct?

In every major research system, the first-line investigator is the researcher’s own institution, not a national regulator. National bodies — ORI, UKRIO, ARIC, and Canada’s SRCR — exist to set standards, provide oversight, and in some cases review procedural fairness, but they rarely re-investigate the underlying facts themselves.

This “institution-first” model is near-universal because misconduct findings usually require discipline-specific expertise, access to lab notebooks, data, and witnesses that only the host institution can readily obtain. National oversight bodies then step in at different points: before a case (setting definitions and required procedures), during it (advising or auditing), or after it (reviewing the outcome or deciding on federal funding consequences).

United States: the Office of Research Integrity (ORI)

The Office of Research Integrity (ORI), part of the US Department of Health and Human Services, oversees misconduct involving research funded by the Public Health Service, including the National Institutes of Health (NIH). ORI does not typically conduct the initial fact-finding itself.

• Institutions receiving PHS funding must maintain written misconduct policies compliant with 42 CFR Part 93, the federal research misconduct regulation.
• Institutions run the inquiry and investigation; ORI oversees the process, can require corrective action, and can impose federal funding debarment.
• The National Science Foundation (NSF) runs a parallel, separate process for NSF-funded research through its Office of Inspector General.
• ORI’s statutory definition of research misconduct — fabrication, falsification, or plagiarism — is the reference definition most other countries cite or adapt.

United Kingdom: institutions advised by UKRIO

The UK has no statutory national investigator. Responsibility sits with the employing university or research organisation, which must operate a misconduct procedure consistent with the Concordat to Support Research Integrity (Universities UK, 2019).

• The UK Research Integrity Office (UKRIO) is an independent charity, not a regulator — it provides advice, a model investigation procedure, and training, but has no statutory power to investigate or sanction.
• UK Research and Innovation (UKRI), the national funder, requires funded organisations to have robust misconduct procedures as a condition of grant funding, per its Grant Research Practice policy.
• The newer UK Committee on Research Integrity (UK CORI) monitors sector-wide research integrity but does not investigate individual cases either.
• Appeals, where permitted, are handled internally by the institution, managed by someone other than the original decision-maker.

Australia: NHMRC, ARC and the Australian Research Integrity Committee

Australia operates a shared responsibility model. Institutions investigate under the Australian Code for the Responsible Conduct of Research (2018), jointly issued by the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), and Universities Australia.

• The Australian Research Integrity Committee (ARIC), a joint NHMRC/ARC initiative, reviews the process an institution followed — not the substance of the misconduct finding — when a complainant or respondent challenges procedural fairness.
• NHMRC and ARC can withdraw or withhold funding from institutions found not to comply with the Code, giving Australia a funding-conditionality lever similar to the US ORI model.
• Unlike the US and UK, Australia has an explicit national committee (ARIC) with a formal review remit, though it stops short of full investigative authority — a gap frequently raised in Australian research-integrity policy debate.

Canada: the Tri-Agency Framework and SRCR

Canada’s three federal granting agencies — the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC), and the Social Sciences and Humanities Research Council (SSHRC) — jointly known as the Tri-Agency, govern misconduct through the Tri-Agency Framework: Responsible Conduct of Research.

• The Secretariat on Responsible Conduct of Research (SRCR) administers the Framework, advises institutions, and tracks cases, but institutions conduct the actual investigation.
• Institutions receiving Tri-Agency funds must sign a Memorandum of Understanding agreeing to investigate allegations under the Framework and report outcomes to the SRCR.
• Consequences for non-compliance can include suspension or termination of Tri-Agency funding to the institution or individual — the same funding-lever mechanism used by ORI and NHMRC/ARC.

Side-by-side comparison of powers and remit

The table below summarises where investigative authority actually sits, and what each national body can and cannot do.

The consistent pattern: every national body relies on funding conditionality — not direct investigative power — as its main enforcement lever. Only the institution has authority to determine the facts of a specific allegation.

Answer-first Q&A

Who investigates research misconduct?

The employing research institution investigates in the US, UK, Australia, and Canada. National bodies such as ORI, UKRIO, ARIC, and the SRCR set standards, provide advice, or review process fairness, but they do not typically conduct the fact-finding themselves — institutional panels of academic peers do.

Which agencies oversee research misconduct?

In the US, the Office of Research Integrity and the institution jointly oversee PHS-funded cases. The NSF Office of Inspector General covers NSF grants separately. In the UK, UKRI sets funding conditions while UKRIO advises. In Australia, NHMRC and ARC jointly run ARIC. In Canada, the Tri-Agency (CIHR, NSERC, SSHRC) oversees via the SRCR.

What counts as research misconduct?

Research misconduct generally means fabrication, falsification, or plagiarism in proposing, performing, reviewing, or reporting research — the core US federal definition. UKRIO frames it more broadly as behaviours that deliberately or recklessly fall short of expected research standards, distinguishing it from honest error or lesser “questionable research practices.”

What happens if research misconduct is confirmed?

Confirmed findings can trigger institutional disciplinary action, correction or retraction of the published record, and notification of funders. National bodies can add consequences: ORI can debar researchers from federal funding; NHMRC/ARC and Canada’s Tri-Agency can suspend or withdraw institutional or individual grant funding.

What this means for institutions and researchers

Institutions operating across borders — a common reality for multinational research collaborations — must satisfy multiple, non-equivalent oversight regimes simultaneously. A joint US-UK-Australia project can trigger three separate procedural obligations: 42 CFR Part 93 compliance for PHS funding, Concordat-aligned procedures for UK partners, and Australian Code compliance for NHMRC/ARC-funded co-investigators.

Research administrators should map which funders and jurisdictions apply before a misconduct concern arises, not after. Confirming institutional procedures satisfy every applicable framework — rather than assuming one national standard covers a whole consortium — reduces the risk of a finding being challenged on procedural grounds in a partner jurisdiction.

The direction of travel in all four systems is toward tighter funder-driven conditionality rather than new statutory investigative powers: expect national bodies to keep strengthening reporting and audit requirements on institutions, rather than assuming direct investigation duties themselves.